Jodas Expoim is a finished-dose manufacturer based in India. It appears in 35 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), ARCSA (EC) and NAFDAC (NG). Its GMP standing is certified by EMA, TMDA (TZ) and ANVISA (Brazil), among 4 authorities. Customs aggregates show $3.4M of exports covering 34 molecules to 4 destinations in 2025.
| Site | FDA FEI |
|---|---|
| TELANGANA, India | Not on file |
| Telangana, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NPRA (MY) | 15 | None |
| ARCSA (EC) | 7 | None |
| NAFDAC (NG) | 4 | 1 |
| UZPHARM (UZ) | 4 | None |
| MINSA (CR) | 3 | None |
| COFEPRIS (MX) | 1 | None |
| EMA | None | 2 |
| TMDA (TZ) | None | 1 |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $11.6M | 10 |
| 2025 | Not reported | $3.4M | 4 |
| 2024 | Not reported | $462K | 1 |
| 2023 | Not reported | $967K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Jodas Expoim comes back tiered against every other supplier able to file there.
Start for free